Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in the number of shares and votes in Projektengagemang Sweden AB (publ) following conversion

The number of shares and votes in Projektengagemang Sweden AB (publ) (Projektengagemang) has changed due to conversion of 900 class A shares to 900 class B shares.Pursuant to the articles of association of Projektengagemang, a holder of a class A share is entitled to request that the share is converted into a class B share. In November 2024, 900 class A shares have been converted into 900 class B shares, at the request of shareholders. After the conversion, as of November 25 2024, the total number of shares and votes in Projektengagemang amounted to 24 555 677 and 71 608 793,

DanCann Pharma A/S Recommends Experienced Politician and Senior Government Official to Join the Board of Directors

COPENHAGEN, Denmark, 25 November 2024 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, is pleased to announce its nomination of Jes Lunde to join its Board of Directors at the upcoming Extraordinary General Meeting, scheduled for 10 December 2024.Jes Lunde brings a wealth of experience to the Company, having served as a Member of the Danish Parliament (Folketinget) from 1984 to 2001, representing the Socialist People’s Party (SF). During his tenure, he held prominent roles, including Group Chairman and Member of the Finance

NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

The Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Tuesday, 10 December 2024 at 09:00 am (CET)at DanCann Pharma A/S’ address, Rugvænget 5, 6823 Ansager, Denmark The agenda for the extraordinary general meeting is as follows: Proposed resolution to elect one (1) new additional member of the board of 1. directors (proposed by the board of directors)  Proposed resolution to issue shares to members of the executive board and 2. board of directors of the Company without pre-

No. 105, 2024 – Debtor composition in Nordea Kredit (CK 92)

Monthly information on debtor composition in Nordea Kredit published in order to comply with the Transparency Directive's disclosure requirements.Nordea Kredit hereby publishes monthly data on debtor composition of all callable bond series. The information is subject to disclosure requirements in the Securities Trading Act § 27a section 1.The information is also published in the usual way via the Copenhagen Stock Exchange / OMX.   Nordea Kredit Realkreditaktieselskab   Søren Søndergaard Phone : +45 61 55 11 58

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 254 – 25 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

Heimstaden Bostad AB (publ) Announces Tender Offer for Its EUR 800 Million Perpetual Hybrid Securities and Mandate for New Hybrid Securities

Tender OfferToday, Heimstaden Bostad AB (publ) (“Heimstaden Bostad”) is launching an offer to the holders of its EUR 800 million perpetual non-call hybrid securities with the first reset date on 19 February 2025 (ISIN XS2010037765) (referred to as the “Hybrid Securities”) to tender any and all of their Hybrid Securities for purchase by Heimstaden Bostad for cash at a fixed purchase price of 100.00% of the nominal amount, plus accrued but unpaid interest up to (but excluding) the settlement date for the tender offer (referred to as the “Tender Offer”).The Hybrid Securities will be

AFRY is the preferred technical partner for Neoen’s Solar farm in Ireland

AFRY has been appointed as the owner’s engineer for a large solar photovoltaic (PV) project in Ballinknockane, Ireland, developed by Neoen. With a capacity of 79 MWp, this large-scale solar plant plays a critical role in advancing the country’s clean energy goals.Neoen, a leading independent renewable energy producer, operates a capacity of 8.7 GW across solar, wind, and storage projects worldwide, actively contributing to the energy transition. The Ballinknockane solar PV project, located in Limerick County, is projected to achieve a capacity of 79 MWp and will include a ground-mounted PV

Change of CEO in Telenor Sweden

At the end of the year, Bjørn Ivar Moen will leave the position as CEO of Telenor Sweden as he returns to Norway. Recruitment of a new CEO is ongoing and will be announced shortly.[Bjrn Ivar Moen VD p Telenor Sverige] “It has been three intense, fun, and of course also sometimes challenging years. We have pushed forward and accomplished great things together. It is with mixed feelings that I have decided to leave good colleagues and a great place to work. However, I am also looking forward to return home to family and friends in Norway as well as exploring the world outside of Telenor,"

Sivers Semiconductors Named Finalist for GSA’s Outstanding EMEA Semiconductor Company Award

Sivers Semiconductors AB (STO:SIVE), a global leader in photonics and wireless technologies, has been named a finalist for the prestigious Outstanding EMEA Semiconductor Company Award by the Global Semiconductor Alliance (GSA) alongside global powerhouse brands. This recognition underscores Sivers’ critical role in advancing high-performance, energy-efficient solutions for AI Data Centers, Satellite Communications and global communications networks.Driving Innovation in AI Data Centers and Satellite Communications At the forefront of solving the most pressing challenges in AI Data

Clinical evaluation at Karolinska University Hospital is progressing

The cancer diagnostics company BiBBInstruments AB ("BiBB or the "Company"), the developer of EndoDrill[®], the world's first market-cleared, electric-driven biopsy instrument for endoscopy, announces that the Company's clinical evaluation is proceeding at Karolinska University Hospital in Stockholm. During the Company's visit to the hospital, Dr. Fredrik Swahn performed biopsy sampling using EndoDrill[® ]GI on three patients with suspected pancreatic tumors, resulting in visible core biopsies in all cases. The hospital was provided with more disposable instruments to complete the evaluation.

Repurchase of Truecaller B shares in week 47, 2024

During 18 November 2024 and 22 November 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 90,000 own B shares (ISIN: SE0016787071), corresponding to 0.03% of outstanding capital, as part of the share buyback programme initiated by the board of directors. Since the start of the programme, in the end of May, approximately 3.9 million B-shares has been repurchased which corresponds to 1.11% of the outstanding capital.The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between

Metsä Group’s tissue paper transports in Scandinavia switch to renewable fuels

PRESS RELEASE 25 NOVEMBER AT 09.45 EET Metsä Group’s tissue paper business is taking an important step towards more sustainable transports of its tissue products by arranging part of its outbound transports to customers in Scandinavia with fossil-free fuels. This shift is part of the company’s strategic Lean Supply Chain programme aiming for efficient and lean value proposition to local markets. Approximately 40 percent of Metsä Tissue Scandinavia’s outbound transports are now powered by HVO or bio-diesel. These biofuel transports represent a vast majority of the outbound transports

QVance’s Partnerships Driving Innovation in Advanced Therapies

NextCell Pharma AB*, parent company of QVance, proudly supports QVance’s newly announced partnership with Royale International. This collaboration, which combines Royale International’s global expertise in logistics with QVance’s innovative quality control solutions, strengthens the supply chain for cell and gene therapies across Europe.This partnership perfectly complements QVance’s existing collaboration with bioMérieux, a global leader in diagnostic equipment and consumables. Together, these partnerships position QVance as a comprehensive service provider, bringing together top-tier

Article published by ASSET, coordinated by Diamyd Medical, advocates for national screening programs in Sweden for early detection of Type 1 Diabetes

An opinion piece article published by members of the ASSET steering group in Göteborgs-Posten, western Sweden’s largest daily morning paper, underscores the need for early detection of Type 1 Diabetes through national screening programs. The article discusses recent advances in disease understanding that enable intervention before symptoms appear, potentially preventing or delaying its onset. The innovation milieu ASSET (AI for Sustainable Prevention of Autoimmunity in the Society), coordinated by Diamyd Medical, is an industry-healthcare partnership financed by the Swedish innovation agency

French hospital joins regional pathology solution from Sectra to enhance collaboration and speed up cancer diagnostics

Linköping, Sweden – November 25, 2024 – International medical imaging IT and cybersecurity company Sectra’s  (STO: SECT B) digital pathology solution will be adopted by the hospital CH Béziers in France. They are the third hospital in the region to choose Sectra, providing them with a powerful platform for collaboration. The solution will enhance workflow efficiency, and minimize variability in pathology reviews, ultimately improving patient care.“Going digital within our pathology operations will provide us with tools necessary for an efficient workflow. It will also

The last day of trading with the warrants of series TO5 in Wyld Networks AB is today, November 25, 2024

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES. Today, November 25, 2024, is the last day of trading with the warrants of series TO5 in Wyld Networks AB (“Wyld Networks” or “the Company”). The subscription period for the warrants of series TO5 runs up until

Dollar assets preferred by Swedish small savers

There is a clear trend for more savings to be invested in US companies. The number of owners of US funds on Nordnet has increased by 36 per cent this year. The marked appreciation of the dollar provides additional fuel for savings-related dollars.Raytelligence's strategy of investing in American "tech" companies comes at a time when the dollar is driving development. The first company is High Speed Interconnects International Corp (”HSI”), with production in the US and Mexico and global demand. The global coaxial cable market was valued at USD 8.1 billion in 2023 and is forecast to reach

QVance Announces Partnership with Royale International to Drive Innovation in End-to-End Cell and Gene Therapy Cold Chain Distribution and Quality Control

QVance has today announced that it has entered into a partnership with Royale International, a global leader in logistics and supply chain management. This collaboration marks a significant milestone in the development of end-to-end cold chain distribution and quality control analytical services solutions for the cell and gene therapy sector.The partnership combines Royale International's extensive expertise in international shipping and logistics management with QVance's innovative solutions in quality analytical services for advanced therapies. Together, the two companies aim to address

DanCann Pharma A/S: The Board of Directors has resolved on directed share issues of DKK 4.5 million and proposal of directed share issues of DKK 0.4 million

COPENHAGEN, Denmark, 25 November 2024 – The Board of Directors of DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has today decided to carry out directed issues of shares and warrants to investors pursuant to an authorisation granted by the general meeting, cf. clause 6.4 of the articles of association. The investors have subscribed for all shares and warrants in the directed issues. Through the directed issues of shares and warrants, the Company will initially receive approximately DKK 4.5 million before deduction of transaction

Corem divests in Borås for SEK 320 million

Corem has signed an agreement for the sale of part of the property Skruven 3 in Borås at an underlying property value of SEK 320 million.   The part of the property that is being sold consists mainly of retail space with a rentable area of approximately 19,000 square meters and a rental value of approximately SEK 23.5 million.   The property, located in Ramnaslätt's industrial area next to national highway 40, was developed by Corem in 2018 and offers a trading place for craftsmen and professionals. The largest tenants are Hornbach, Bevego and Snabbgross.   Planned

Africa Oil Announces Results of Share Buyback Program

VANCOUVER, BC, Nov. 25, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) - Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 606,900 Africa Oil common shares during the period of November 18, 2024 to November 22, 2024 under the previously announced share buyback program. The launch of Africa Oil’s normal course issuer bid (share buyback) program, announced by the Company on December 4, 2023, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No 2016/

Truqap improved rPFS in advanced prostate cancer

25 November 2024 Truqap combination in PTEN-deficient metastatic hormone-sensitiveprostate cancer demonstrated statistically significant and clinically meaningfulimprovement in radiographic progression-free survivalin CAPItello-281 Phase III trial First and only AKT inhibitor combination to demonstratebenefit in this specific subtype of prostate cancer Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca's Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a statistically

SCA signs a new credit facility agreement of SEK 6 billion

Svenska Cellulosa Aktiebolaget SCA (publ) has signed a new credit facility of SEK 6 billion. The new facility is a refinancing of the current undrawn credit facility of SEK 5 billion, which was signed in 2019. The credit facility is primarily a back-up facility that will remain undrawn and serve as a liquidity reserve for the company.The facility has a maturity of 5 years containing two extension options of 1 year each. Participating banks are Danske Bank, Skandinaviska Enskilda Banken, Svenska Handelsbanken, and Swedbank, all acting as “Mandated Lead Arrangers” and “Bookrunners”. Swedbank

There are no items matching the current filter
There are no more items matching the current filter
Back to top